PL374898A1 - Metoda ulepszonej diagnostyki dysplazji - Google Patents

Metoda ulepszonej diagnostyki dysplazji

Info

Publication number
PL374898A1
PL374898A1 PL03374898A PL37489803A PL374898A1 PL 374898 A1 PL374898 A1 PL 374898A1 PL 03374898 A PL03374898 A PL 03374898A PL 37489803 A PL37489803 A PL 37489803A PL 374898 A1 PL374898 A1 PL 374898A1
Authority
PL
Poland
Prior art keywords
dysplasia
improved diagnosis
diagnosis
improved
Prior art date
Application number
PL03374898A
Other languages
English (en)
Other versions
PL214860B1 (pl
Inventor
Ruediger Ridder
Anja Reichert
Marcus Trunk-Gehmacher
Richard Batrla
Original Assignee
Mtm Laboratories Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02024030A external-priority patent/EP1416278B1/en
Application filed by Mtm Laboratories Ag filed Critical Mtm Laboratories Ag
Publication of PL374898A1 publication Critical patent/PL374898A1/pl
Publication of PL214860B1 publication Critical patent/PL214860B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL374898A 2002-10-28 2003-10-21 Sposób i zestaw do rozrózniania komórek dysplastycznych PL214860B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02024030A EP1416278B1 (en) 2002-10-28 2002-10-28 Method for improved diagnosis of dysplasias
EP03100584A EP1422526A1 (en) 2002-10-28 2003-03-07 Method for improved diagnosis of dysplasias

Publications (2)

Publication Number Publication Date
PL374898A1 true PL374898A1 (pl) 2005-11-14
PL214860B1 PL214860B1 (pl) 2013-09-30

Family

ID=32178671

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374898A PL214860B1 (pl) 2002-10-28 2003-10-21 Sposób i zestaw do rozrózniania komórek dysplastycznych

Country Status (9)

Country Link
US (8) US20070128599A1 (pl)
EP (2) EP1422526A1 (pl)
JP (3) JP2006503589A (pl)
AU (1) AU2003301564A1 (pl)
CA (1) CA2496465C (pl)
DK (1) DK1556701T3 (pl)
ES (1) ES2391893T3 (pl)
PL (1) PL214860B1 (pl)
WO (1) WO2004038418A1 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
DK1388734T3 (da) 2002-08-01 2004-05-03 Mtm Lab Ag Metode til opløsningsbaseret diagnose
US8951746B2 (en) 2004-11-05 2015-02-10 Southwest Research Institute Method and devices for screening cervical cancer
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
US8131476B2 (en) 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
GB0720113D0 (en) 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
US8728745B2 (en) * 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
WO2011098262A2 (en) * 2010-02-09 2011-08-18 Universität Bremen P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
JP5553661B2 (ja) * 2010-03-30 2014-07-16 シスメックス株式会社 癌の再発リスク判定方法
US20120053253A1 (en) * 2010-07-07 2012-03-01 Myriad Genetics, Incorporated Gene signatures for cancer prognosis
EP2611941A4 (en) 2010-08-30 2014-01-22 Myriad Genetics Inc GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
EP2638396B1 (en) 2010-11-12 2017-03-01 incellDX, Inc. Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
ES2938766T3 (es) 2012-11-16 2023-04-14 Myriad Genetics Inc Firmas génicas para el pronóstico de cáncer
EP3143160B1 (en) 2014-05-13 2019-11-06 Myriad Genetics, Inc. Gene signatures for cancer prognosis
CN104807788B (zh) * 2014-12-18 2018-09-14 中山大学 一种用于监测血管重构现象的方法与试剂盒
EP4060344A1 (en) 2015-06-08 2022-09-21 Arquer Diagnostics Limited Methods and kits
JP6854246B2 (ja) 2015-06-08 2021-04-07 アーケア ダイアグノスティクス リミテッド 尿サンプルの分析方法
WO2016207414A1 (en) 2015-06-25 2016-12-29 Universitaet Des Saarlandes Improved diagnostic method for hpv-induced cancer and precancerous lesion screening and diagnosis
CN105241698A (zh) * 2015-09-25 2016-01-13 四川农业大学 一种黄石爬鮡皮肤石蜡切片的制作方法
US10300153B2 (en) * 2015-11-30 2019-05-28 Asthra, Llc Immunological detection of altered cells
JP6702339B2 (ja) * 2015-12-24 2020-06-03 コニカミノルタ株式会社 画像処理装置及びプログラム
RU2019100441A (ru) * 2016-06-13 2020-07-14 Конинклейке Филипс Н.В. Способ логического вывода об активности транскрипционного фактора пути сигнальной трансдукции у субъекта
US12522862B2 (en) 2017-10-23 2026-01-13 The University Of Western Australia Cell analysis
WO2019234176A1 (en) 2018-06-07 2019-12-12 Universitaet Des Saarlandes Novel biomarkers for carcinoma diagnosis
CN110553889A (zh) * 2019-09-18 2019-12-10 宋建华 自动染色机He染色工艺
EP3816934B1 (en) 2019-11-04 2025-01-01 UMMON HealthTech Method of, and computerized system for labeling an image of cells of a patient
CN111077302A (zh) * 2019-12-26 2020-04-28 江苏美克医学技术有限公司 一种基于葡聚糖信号放大ki67和p16INK4a检测试剂盒
EP4217746A1 (en) * 2020-09-24 2023-08-02 Cytosystems Limited Diagnosis of cancer by imaging flow cytometry
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
JP2025507447A (ja) * 2022-02-01 2025-03-18 ４ディー・パス・インコーポレイテッド 画像に基づく疾患特性評価のためのシステム及び方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
JPH087229A (ja) * 1994-06-13 1996-01-12 Sony Corp 磁気抵抗効果型磁気ヘッド
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5723313A (en) * 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) * 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
EP1025444B1 (en) 1997-10-21 2005-03-02 Cancer Research Technology Limited Determination of cellular growth abnormality
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
DE19957689A1 (de) 1999-11-30 2001-06-13 Deutsches Krebsforsch Proteaseresistenter Tumorsuppressor p14(ARF)
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063112A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE10063179A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
EP1373896A2 (en) * 2001-03-12 2004-01-02 MonoGen, Inc. Cell-based detection and differentiation of disease states
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1387173A1 (en) * 2002-07-29 2004-02-04 MTM Laboratories AG Method for improved diagnosis of cervical lesions based on detection of INK4a gene products
US20050272038A1 (en) 2002-07-29 2005-12-08 Ruediger Ridder Compositions and methods for diagnosis and therapy of cancers
DK1388734T3 (da) 2002-08-01 2004-05-03 Mtm Lab Ag Metode til opløsningsbaseret diagnose
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
US8728745B2 (en) 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors
US8277190B2 (en) 2009-03-27 2012-10-02 General Electric Company Turbomachine rotor assembly and method

Also Published As

Publication number Publication date
US8367353B2 (en) 2013-02-05
EP1422526A1 (en) 2004-05-26
DK1556701T3 (da) 2012-11-19
US20210047697A1 (en) 2021-02-18
AU2003301564A8 (en) 2004-05-13
WO2004038418A1 (en) 2004-05-06
US8975036B2 (en) 2015-03-10
CA2496465C (en) 2010-08-17
US20130189686A1 (en) 2013-07-25
JP5442884B2 (ja) 2014-03-12
EP1556701B1 (en) 2012-08-15
ES2391893T3 (es) 2012-11-30
JP2006503589A (ja) 2006-02-02
US20130189685A1 (en) 2013-07-25
US9528159B2 (en) 2016-12-27
US20200017923A1 (en) 2020-01-16
US20090176204A1 (en) 2009-07-09
JP2009142294A (ja) 2009-07-02
JP2013150616A (ja) 2013-08-08
US20210071267A1 (en) 2021-03-11
CA2496465A1 (en) 2004-05-06
EP1556701A1 (en) 2005-07-27
US20090068675A1 (en) 2009-03-12
PL214860B1 (pl) 2013-09-30
US20070128599A1 (en) 2007-06-07
AU2003301564A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
PL374898A1 (pl) Metoda ulepszonej diagnostyki dysplazji
DE60316652D1 (de) Endoskop
BRPI0313238A2 (pt) método
DE60327287D1 (de) Aufzeichnungsgerät
DE60312848D1 (de) Verbindungsanschluss
NO20044046L (no) Substituerte hydroksyetylaminer
ITTO20030629A1 (it) Procedimento di realizzazione di collegamenti ad
DE60315105D1 (de) Ozonisator
DE50310866D1 (de) Flanschverbindung
DE50303155D1 (de) Dichtring
NO20040269L (no) Telemetrisystem
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
DE60303409D1 (de) Aufzeichnungsgerät
DE60314958D1 (de) Reissverschluss
DE60320339D1 (de) Aufzeichnungsgerät
FI20012603L (fi) Diagnostinen menetelmä
DE60303241D1 (de) Aufzeichnungsgerät
NO20023358D0 (no) Metode
DE60314791D1 (de) Aufzeichnungsgerät
FR2843451B1 (fr) Fronde du type lance-pierres
ITTO20020997A1 (it) Procedimento autoalllineato per la fabbricazione di
ATE350379T1 (de) Substituierte benzdioxepine
FI20021381L (fi) Kaivo